Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-93.63	3.52	55.22
Graham Fair Price	-97.01	2.44	81.57
PEG	51.70	< 0.005	< 0.005
Price/Book	129686.86	861.56	0.66
Price/Cash Flow	-63.34	-4.00	-2.45
Prices/Earnings	18.68	1.10	-0.93
Price/Sales	-93.95	1.31	21.58
Price/FCF	-63.34	-4.00	-2.45
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-69.71	1.00	3.30
Operating Margin	-93.47	0.37	-5.68
ROA	95674.19	3.45	< 0.005
ROE	-0.18	195.93	109254.53
ROIC	-0.07	98.03	136344.84
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-1.00	0.03	3309.80
Dividends QOQ	-0.22	0.27	26.20
EBIT QOQ	-2.18	2.27	4.08
EPS QOQ	-2.51	1.96	-21.77
FCF QOQ	-41.61	0.28	-99.32
Revenue QOQ	-0.95	18.42	1839.33
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	9743.79	0.00	inf
Days Sales Outstanding (DSO)	12669.20	644.19	-94.92
Inventory Turnover	< 0.005	0.00	inf
Debt/Capitalization	0.46	0.50	7.86
Quick Ratio	-1.75	-2634.21	-150197.19
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	40.63	0.04	-99.91
Cash	44.92	118.61	164.03
Capex	0.00	0.00	0.00
Free Cash Flow	-11.01	-7.90	28.27
Revenue	1.25	24.20	1837.08
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	-0.41	-0.28	31.58
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	20.55	< 0.005	-99.99
Naive Interpretation	Member

06 - Financial Health · Bad

Rating